On 18 & 19 November 2019, the European Medicines Agency convened stakeholders (including EUCROF, which was represented by its President, Dr Martine Dehlinger Kremer) for a workshop to discuss the outcome of the public consultation on the draft Regulatory Science Strategy to 2025, reflect on the prioritisation of core recommendations and identify concrete actions to implement the key goals and recommendations.
The draft strategy sets out working proposals on the key areas with which EMA intends to engage, in order to ensure that it has the regulatory tools to continue supporting the European Medicines Regulatory Network and fulfil its ongoing mission in light of upcoming scientific challenges.
The final strategy, expected in early 2020, will be a key contribution to the next EU Medicines Agencies Network Strategy (2020-2025) in addition to the Agency’s scientific committees’ and working parties’ workplans through to 2025.
One of the aims of the workshop was to identify concrete actions to implement the key goals and recommendations.
The participants included patient representatives, healthcare professionals, academia, health technology assessment bodies, payers’ organisations, trade associations and regulators.
The event was by invitation only.
